Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

被引：0
|
作者：
Bromberg, Jacoline
Issa, Samar
Bukanina, Katerina
Minnema, Monique C.
Seute, Tatjana
Durian, Marc
Cull, Gavin
Schouten, Harry C.
Stevens, Wendy B.
Zijlstra, Josee
Baars, Johanna W.
Nijland, Marcel
Mason, Kylie
Beeker, Aart
van den Bent, Martin
de Jong, Daphne
Gonzales, Michael Anthony
Doorduijn, Jeanette K.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
582
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study.
    Lugtenburg, Elly J.
    Brown, Peter
    van der Holt, Bronno
    D'Amore, Francesco
    Koene, Harry R.
    de Jongh, Eva
    Fijnheer, Rob
    Loosveld, Olaf
    Bohmer, Lara H.
    Pruijt, Hans
    Verhoef, Gregor
    Hoogendoorn, Mels
    Bilgin, Yavuz
    Nijland, Marcel
    Lam, King H.
    de Keizer, Bart
    de Jong, Daphne
    Zijlstra, Josee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.
    Lugtenburg, Pieternella J.
    Brown, Peter de Nully
    van der Holt, Bronno
    D'Amore, Francesco
    Koene, Harry R.
    Berenschot, Henriette W.
    Fijnheer, Rob
    Loosveld, Olaf
    Bohmer, Lara H.
    Pruijt, Hans
    Verhoef, Gregor
    Hoogendoorn, Mels
    de Kan, Romko
    Van Imhoff, Gustaaf Willem
    van Hooije, Christel
    Lam, King H.
    de Keizer, Bart
    de Jong, Daphne
    Hoekstra, Otto S.
    Zijlstra, Josee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma
    Yuan, Xianggui
    Xie, Yaping
    Xu, Nengwen
    Liu, Hui
    Chen, Panpan
    Zhao, Aiqi
    Liang, Yun
    Qian, Wenbin
    HAEMATOLOGICA, 2024, 109 (06) : 2005 - 2009
  • [34] METHOTREXATE-RITUXIMAB TREATMENT IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CASE REPORT
    Can, E. Saribacak
    Malkan, U.
    Albayrak, M.
    Gunes, G.
    LEUKEMIA RESEARCH, 2017, 61 : S36 - S36
  • [35] Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
    Murakami, Mineko
    Fujimaki, Takamitsu
    Asano, Shuichiro
    Nakaguchi, Hiroshi
    Yamada, Shoko M.
    Hoya, Katsumi
    Yamazaki, Kazuto
    Ishida, Yasuo
    Matsuno, Akira
    YONSEI MEDICAL JOURNAL, 2011, 52 (06) : 1031 - 1034
  • [36] The pharmacokinetics of methotrexate with and without rituximab in the treatment of primary central nervous system lymphoma (PCNSL)
    Rawat, F. R.
    Nolan, A.
    Teo, S. Y.
    Triggs, M.
    Carroll, G.
    Picardo, S.
    Keegan, N. M.
    Mallett, V.
    Ismail, I.
    Hennessy, B.
    Grogan, W.
    Breathnach, O.
    Morris, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Chukwueke, Ugonma
    Wright, Isobel
    Muzikansky, Alona
    Russ, Alyssa
    Fontana, Brittney
    Kats, Vanessa
    O'Donnell, Colin
    Scalfani, Renee
    Acevedo-Naranjo, Brenda
    Lee, Eudocia
    Castro, Luis Nicolas Gonzalez
    McFaline-Figueroa, Jose Ricardo
    Aquilanti, Elisa
    Youssef, Gilbert
    Beroukhim, Rameen
    Forst, Deborah
    Reardon, David
    Wen, Patrick
    Batchelor, Tracy
    Torres, Alexandra
    Stefanik, Jennifer
    Fisher, Jennifer
    Meredith, David
    Murakami, Mark
    Garcia, Yuri
    Shipp, Margaret
    Nayak, Lakshmi
    NEURO-ONCOLOGY, 2023, 25
  • [38] RANDOMIZED PHASE III STUDY OF EARLY RITUXIMAB INTENSIFICATION IN COMBINATION WITH CHOP14 FOLLOWED BY RITUXIMAB OR NO MAINTENANCE IN DIFFUSE LARGE B-CELL LYMPHOMA: A HOVON-NORDIC LYMPHOMA GROUP STUDY
    Lugtenburg, P.
    Brown, P. de Nully
    van der Holt, B.
    d'Amore, F.
    Koene, H.
    Berenschot, H.
    Fijnheer, R.
    Loosveld, O.
    Bohmer, L.
    Pruijt, J.
    Verhoef, G.
    Hoogendoorn, M.
    de Kan, R.
    van Imhoff, G.
    van Hooije, C.
    Lam, K.
    de Keizer, B.
    de Jong, D.
    Hoekstra, O.
    Zijlstra, J.
    HAEMATOLOGICA, 2016, 101 : 173 - 173
  • [39] Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study
    Doorduijn, Jeanette K.
    van Imhoff, Gustaaf W.
    van der Holt, Bronno
    Schouten, Harry C.
    Schaafsma, Martijn R.
    MacKenzie, Marius A.
    Baars, Joke W.
    Kersten, Marie Jose
    Lugtenburg, Pieternella J.
    van den Bent, Martin J.
    Enting, Roelien H.
    Spoelstra, Fokje M.
    Poortmans, Philip
    Bromberg, Jacoline E. C.
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 497 - 503
  • [40] Preliminary Results of Penpulimab Combined with RMA (rituximab, methotrexate, and cytarabine) for Newly Diagnosed Primary Central Nervous System Lymphoma
    Shen, Haorui
    Wu, Jia-Zhu
    Liang, Jin-Hua
    Yin, Hua
    Wang, Li
    Li, Jianyong
    Xu, Wei
    BLOOD, 2022, 140 : 3821 - 3822
12345